Stay updated on Anetumab Ravtansine Multi-indication Clinical Trial
Sign up to get notified when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.

Latest updates to the Anetumab Ravtansine Multi-indication Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe footer now displays Revision: v3.6.3, replacing the previous v3.6.2. This reflects a small platform update with no changes to the study details or navigation visible to users.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2 in the page footer, indicating a minor version update. The change does not modify page content or user-facing features.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page now states that the study is no longer looking for participants, indicating recruitment has closed. Additional sections were added for How to Read a Study Record, Common Questions, How to Join a Study, and the Intervention/Treatment header formatting.SummaryDifference0.3%

- Check46 days agoChange DetectedFooter revision label updated from v3.5.4 to v3.5.5, indicating a new page revision has been published. The update does not modify study details or page content.SummaryDifference0.0%

- Check68 days agoChange DetectedA new revision tag v3.5.4 was added, replacing v3.5.3, indicating a routine site update without changes to the study details or page content.SummaryDifference0.0%

- Check89 days agoChange DetectedClinicalTrials.gov’s page version indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a site release rather than a change to the trial content.SummaryDifference0.0%

Stay in the know with updates to Anetumab Ravtansine Multi-indication Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anetumab Ravtansine Multi-indication Clinical Trial page.